Literature DB >> 26228531

Human papillomavirus infection and p16 overexpression in oropharyngeal squamous cell carcinoma: a case series from 2010 to 2014.

Maria Gabriella Donà1, Giuseppe Spriano2, Barbara Pichi2, Francesca Rollo3, Valentina Laquintana3, Renato Covello3, Raul Pellini2, Massimo Giuliani1, Edoardo Pescarmona3, Maria Benevolo3.   

Abstract

AIM: Human papillomavirus (HPV) associated oropharyngeal squamous cell carcinomas (OPSCC) show better prognosis and response to therapy. We evaluated HPV-DNA prevalence, p16 overexpression and HPV-attributable fraction in recent consecutive OPSCCs. MATERIALS &
METHODS: 140 OPSCCs were analyzed for HPV-DNA using the INNO-LiPA assay and p16 overexpression using CINtec® Histology kit.
RESULTS: HPV-DNA prevalence was 40.7%, and was significantly higher in basaloid and nonkeratinizing SCCs, but similar in tonsillar and base of tongue SCCs. Moreover, 98.0% of the HPV-positive OPSCCs overexpressed p16, compared with 12.3% of the HPV-negative cases (p < 0.0001). Based on HPV-DNA and p16 double positivity, 39.8% of the cases were HPV related.
CONCLUSION: The high estimate of the HPV-attributable fraction suggests that a substantial proportion of OPSCC patients may be managed less intensively.

Entities:  

Keywords:  head and neck neoplasms; human papillomavirus; oropharyngeal neoplasms; p16INK4 protein; prevalence

Mesh:

Substances:

Year:  2015        PMID: 26228531     DOI: 10.2217/FMB.15.55

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  9 in total

1.  Promoter DNA Methylation and mRNA Expression Level of p16 Gene in Oral Squamous Cell Carcinoma: Correlation with Clinicopathological Characteristics.

Authors:  Abdolamir Allameh; Abdolkarim Moazeni-Roodi; Iraj Harirchi; Mehrdad Ravanshad; Maziar Motiee-Langroudi; Ata Garajei; Azin Hamidavi; Seyed Alireza Mesbah-Namin
Journal:  Pathol Oncol Res       Date:  2018-12-03       Impact factor: 3.201

2.  Characterization of High-Risk HPV/EBV Co-Presence in Pre-Malignant Cervical Lesions and Squamous Cell Carcinomas.

Authors:  Rancés Blanco; Diego Carrillo-Beltrán; Juan P Muñoz; Julio C Osorio; Julio C Tapia; Verónica A Burzio; Iván Gallegos; Gloria M Calaf; Paola Chabay; Francisco Aguayo
Journal:  Microorganisms       Date:  2022-04-24

Review 3.  Human papillomavirus and head and neck carcinomas: focus on evidence in the babel of published data.

Authors:  P Morbini; M Benazzo
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-08       Impact factor: 2.124

Review 4.  Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years.

Authors:  Linnea Haeggblom; Torbjörn Ramqvist; Massimo Tommasino; Tina Dalianis; Anders Näsman
Journal:  Papillomavirus Res       Date:  2017-05-19

5.  High prevalent human papillomavirus infections of the oral cavity of asymptomatic HIV-positive men.

Authors:  Rocío Méndez-Martínez; Silvia Maldonado-Frías; Salvador Vázquez-Vega; Yanink Caro-Vega; José Guadalupe Rendón-Maldonado; Miriam Guido-Jiménez; Brenda Crabtree-Ramírez; Juan G Sierra-Madero; Alejandro García-Carrancá
Journal:  BMC Infect Dis       Date:  2020-01-10       Impact factor: 3.090

Review 6.  Current status and future of delivery systems for prevention and treatment of infections in the oral cavity.

Authors:  Sevda Şenel; Ayben Işılay Özdoğan; Gülçin Akca
Journal:  Drug Deliv Transl Res       Date:  2021-03-26       Impact factor: 4.617

7.  Human papillomavirus (HPV) and Epstein-Barr virus (EBV) in keratinizing versus non- keratinizing squamous cell carcinoma of the oropharynx.

Authors:  Francesco Broccolo; Giulia Ciccarese; Agostino Rossi; Luca Anselmi; Francesco Drago; Antonio Toniolo
Journal:  Infect Agent Cancer       Date:  2018-11-09       Impact factor: 2.965

Review 8.  High-Risk Human Papillomavirus and Epstein-Barr Virus Coinfection: A Potential Role in Head and Neck Carcinogenesis.

Authors:  Rancés Blanco; Diego Carrillo-Beltrán; Alejandro H Corvalán; Francisco Aguayo
Journal:  Biology (Basel)       Date:  2021-11-26

9.  HPV sensitizes OPSCC cells to cisplatin-induced apoptosis by inhibiting autophagy through E7-mediated degradation of AMBRA1.

Authors:  Manuela Antonioli; Benedetta Pagni; Tiziana Vescovo; Rob Ellis; Benjamin Cosway; Francesca Rollo; Veronica Bordoni; Chiara Agrati; Marie Labus; Renato Covello; Maria Benevolo; Giuseppe Ippolito; Max Robinson; Mauro Piacentini; Penny Lovat; Gian Maria Fimia
Journal:  Autophagy       Date:  2020-11-23       Impact factor: 16.016

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.